Tag Archives: Covaxin

By: Express News Service | Pune | Updated: October 23, 2020 7:49:23 pm Covaxin: the country’s first indigenous vaccine is an inactivated one created from the infectious virus strain SARS-CoV-2. After successfully completing the interim analysis of the COVAXIN phase 1 and 2 clinical trials, Bharat Biotech has received approval …

India’s Bharat Biotech is in talks with more than 10 countries that have shown interest in a possible Covid-19 vaccine it is developing with a government agency, a company executive told Reuters on Friday. The Hyderabad-based company this week received initial approval from Indian authorities to conduct late-stage trials for …

In response from RTI, NCDC says the WHO official sent an “alert mail” to the Union Minister of Health The World Health Organization (WHO) informed India as early as January 11 that the reported dates of appearance of the new coronavirus circulating in Wuhan in China ranged from “December 12 …

NEW DELHI: Bharat Biotech International Ltd plans to launch its covid-19 vaccine, Covaxin, by June next year, unless the government decides to grant the vaccine an emergency use authorization before then, based on data from earlier phases of clinical trials. CEO Sai Prasad told Mint. “If the government has the …

India’s first coronavirus disease (Covid-19) candidate vaccine, Covaxin, which is being developed by Bharat Biotech, is likely to be at least 60% effective. On Thursday evening, the company received approval from the Controller General of Medicines of India (DCGI) to conduct a phase 3 clinical trial to establish the efficacy …

Covaxin, a candidate vaccine developed indigenously by Bharat Biotech, obtained authorization for the phase three trial in India. A leading source said that rehearsals will begin in the first week of November. The source further said that 18-19 sites have been selected for the trial and more than 22,000 volunteers …

Bharat Biotech had said it plans to cover 28,500 subjects in its phase 3 trial. New Delhi: Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR), has been approved for the third phase of clinical trials. The Hyderabad-based vaccine maker …

India was one of the first countries to adopt a “flexible” lockdown approach and thus managed to keep death rates from COVID-19 relatively low, Prime Minister Narendra Modi said at the launch of the Annual Meeting of Large Challenges, organized by the Bill and Melinda Gates Foundation. The three-day program …

The head of the National Group of Experts on Vaccine Administration for COVID-19 emphasized the appropriate behavior of COVID-19 during the festival season and winter months. The number of new coronavirus cases and deaths has declined in the past three weeks as the spread of the pandemic has leveled off …

Modi also warned against any complacency in the face of the decline and called for continued efforts to contain the pandemic. Prime Minister Narendra Modi has said that every step in the logistics, delivery and administration of the COVID-19 vaccine must be rigorously implemented and must include advanced planning of …